The selective estrogen receptor modulator, bazedoxifene, reduces ischemic brain damage in male rat

Neuroscience Letters

Volumn 575, Issue , 2014, Pages 53-57

  Castelló Ruiz, María ^a,b   Torregrosa, Germán ^a,b   Burguete, María C ^b   Miranda, Francisco J ^b   Centeno, José M ^b   López Morales, Mikahela A ^b   Gasull, Teresa ^c   Alborch, Enrique ^a,b  

^a INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

17 Estradiol; Bazedoxifene; Ischemic stroke; Neuroprotection; Selective estrogen receptor modulators (SERMs)

Indexed keywords

BAZEDOXIFENE; ESTRADIOL; INDOLE DERIVATIVE; NEUROPROTECTIVE AGENT; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; WISTAR RAT; ANIMAL; BRAIN; BRAIN INFARCTION; DRUG EFFECTS; HEMODYNAMICS; ISCHEMIC ATTACK, TRANSIENT; PATHOLOGY; PATHOPHYSIOLOGY; VASCULARIZATION;

ANIMALS; BRAIN; BRAIN INFARCTION; ESTRADIOL; HEMODYNAMICS; INDOLES; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; RATS, WISTAR; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 84902013133     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.05.024     Document Type: Article

References (35)

1. Inagaki T., Etgen A.M. Neuroprotective action of acute strogens: animal models of brain ischemia and clinical implications. Steroids 2013, 78:597-606.
2. Schreihofer D.A., Ma Y. Estrogen receptors and ischemic neuroprotection: who, what, where and when?. Brain Res. 2013, 1514:107-122.
3. Henderson V.W., Lobo R.A. Hormone therapy and the risk of stroke: perspectives 10 years after the Women's Health Initiative trials. Climateric 2012, 15:229-234.
4. Taylor H.S. Designing the ideal selective estrogen receptor modulator-an achievable goal?. Menopause 2009, 16:609-615.
5. Burguete M.C., Torregrosa G., Pérez-Asensio F.J., Castelló-Ruiz M., Salom J.B., Gil J.V., Alborch E. Dietary phytoestrogens improve stroke outcome after transient focal cerebral ischemia in rats. Eur. J. Neurosci. 2006, 23:703-710.
6. Castelló-Ruiz M., Torregrosa G., Burguete M.C., Salom J.B., Gil J.V., Miranda F.J., Jover-Mengual T., Marrachelli V.G., Alborch E. Soy-derived phytoestrogens as preventive and acute neuroprotectors in experimental ischemic stroke: influence of rat strain. Phytomedicine 2011, 18:513-515.
7. Cortina B., Torregrosa G., Castelló-Ruiz M., Burguete M.C., Moscardó A., Latorre A., Salom J.B., Vallés J., Santos M.T., Alborch E. Improvement of the circulatory function partially accounts for the neuroprotective action of the phytoestrogen genistein in experimental ischemic stroke. Eur. J. Pharmacol. 2013, 708:88-94.
8. Lovekamp-Swan T., Glendenning M., Schreihofer D.A. A high soy diet reduces programmed cell death and enhances bcl-xL expression in experimental stroke. Neuroscience 2007, 148:644-652.
9. Schreihofer D.A., Do K.D., Schreihofer A.M. High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R103-R108.
10. DonCarlos L.L., Azcoitia I., Garcia-Segura L.M. Neuroprotective actions of selective estrogen receptor modulators. Psychoneuroendocrinology 2009, 34S:S113-S122.
11. Arevalo M.A., Diz-Chaves Y., Santos-Galindo M., Bellini M.J., Garcia-Segura L.M. Selective oestrogen receptor modulators decrease the inflammatory response of glial cells. J. Neuroendocrinol. 2011, 24:183-190.
12. Duggan S.T., McKeage K. Bazedoxifene: a review of its use in the treatment of postmenopausal osteoporosis. Drugs 2011, 71:2193-2212.
13. Ciriza I., Carrero P., Azcoitia I., Lundeen S.G., Garcia-Segura L. Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol. J. Neurobiol. 2004, 61:209-221.
14. Cerciat M., Unkila M., Garcia-Segura L.M., Arevalo M.A. Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro. Glia 2010, 58:93-102.
15. Suzuki S., Brown C.M., Wise P.M. Neuroprotective effects of estrogens following ischemic stroke. Front. Neuroendocrinol. 2009, 30:201-211.
16. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
17. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986, 17:1304-1308.
18. Strom J.O., Theodorsson A., Theodorsson E. Dose-related neuroprotective versus neurodamaging effects of estrogens in rat cerebral ischemia: a systematic analysis. J. Cerebr. Blood Flow Metab. 2009, 29:1359-1372.
19. Strom J.O., Ingberg E., Theodorsson E., Theodorsson A. Effects of high and low 17β-estradiol doses on focal cerebral ischemia: negative results. Sci. Rep. 2013, 10.1038/srep03111.
20. Ma Y.L., Qin P., Li Y., Shen L., Wang S.Q., Dong H.L., Hou W.G., Xiong L.Z. The effects of different doses of estradiol (E2) on cerebral ischemia in an in vitro model of oxygen and glucose deprivation and reperfusion and in a rat model of middle carotid artery occlusion. BMC Neurosci. 2013, 10.1186/1471-2202-14-118.
21. Zhang B., Subramanian S., Dziennis S., Jia J., Uchida M., Akiyoshi K., Migliati E., Lewis A.D., Vandenbark A.A., Offner H., Hurn P.D., Estradiol G1 reduce infarct size and improve immunosuppression after experimental stroke. J. Immunol. 2010, 184:4087-4094.
22. Liu R., Wang X., Liu Q., Yang S.-H., Simpkins J.W. Dose dependence and therapeutic window for the neuroprotective effects of 17β-estradiol when administered after cerebral ischemia. Neurosci. Lett. 2007, 415:237-241.
23. McCullough L.D., Alkayed N.J., Traystman R.J., Williams M.J., Hurn P.D. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke 2001, 32:796-802.
24. Toung T.J.K., Traystman R.J., Hurn P.D. Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 1998, 29:1666-1670.
25. Yang S.-H., Shi J., Day A.L., Simpkins J.W. Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 2000, 31:745-750.
26. 14C]bazedoxifene in healthy postmenopausal women. Drug Metab. Dispos. 2009, 37:1219-1225.
27. Chandrasekaran A., Ahmad S., Shen L., DeMaio W., Hultin T., Scatina J. Disposition of bazedoxifene in rats. Xenobiotica 2010, 40:578-585.
28. Westberry J.M., Prewitt A.K., Wilson M.E. Epigenetic regulation of the estrogen receptor alpha promoter in the cerebral cortex following ischemia in male and female rats. Neuroscience 2008, 152:982-989.
29. Herson P.S., Bombardier C.G., Parker S.M., Shimizu T., Klawitter J., Klawitter J., Quillinan N., Exo J.L., Goldenberg N.A., Traystman R.J. Experimental pediatric arterial ischemic stroke model reveals sex-specific estrogen signaling. Stroke 2013, 44:759-763.
30. Sak K., Everaus H. Nongenomic effects of 17β-estradiol-diversity of membrane binding sites. J. Steroid Biochem. Mol. Biol. 2004, 88:323-335.
31. Komm B.S., Kharode Y.P., Bodine P.V., Harris H.A., Miller C.P., Lyttle C.R. Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity. Endocrinology 2005, 146:3999-4008.
32. Liu M., Kelley M.H., Herson P.S., Hurn P.D. Neuroprotection of sex steroids. Minerva Endocrinol. 2010, 35:127-143.
33. 2+ entry inhibition. J. Cerebr. Blood Flow Metab. 2001, 21:422-429.
34. Torregrosa G., Burguete M.C., Pérez-Asensio F.J., Salom J.B., Gil J.V., Alborch E. Pharmacological profile of phytoestrogens in cerebral vessels: in vitro study with rabbit basilar artery. Eur. J. Pharmacol. 2003, 482:227-234.
35. Salom J.B., Castelló-Ruiz M., Pérez-Asensio F.J., Burguete M.C., Torregrosa G., Alborch E. Acute effects of three isoflavone class phytoestrogens and a mycoestrogen on cerebral microcirculation. Phytomedicine 2007, 14:556-562.